ArticleSmall GTPases
A novel anti-microbial function for a familiar Rab GTPase.
Article in Small GTPases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Modulation of host Rab GTPases by Salmonella: mechanisms of immune evasion and intracellular replication.Molecular biology reports · 2025Review
- Bacterial Secretion Systems: An Overview.Microbiology spectrum · 2016Review
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Salmonella enterica is a bacterial pathogen that closely interacts with its host and replicates intracellularly. It has evolved the ability to create an intracellular membrane vacuole where it can survive and replicate. The nature of the Salmonella vacuole is still poorly understood, and although it has some features in common with lysosomes, it serves as a suitable niche for its survival. In contrast to broad-host Salmonella enterica serovars, Salmonella enterica serovar Typhi (S. Typhi) is a host-adapted pathogen that does not have the ability to replicate in any species other than humans. Such host adaptation is manifested at the single cell level since this pathogen is unable to survive in non-human macrophages. We recently reported that a pathway dependent on the Rab GTPase Rab32 and its guanine-nucleotide exchange factor BLOC-3 restricts the growth and survival of S. Typhi in non-permissive macrophages. We also found that broad host Salmonellae, such as S. Typhimurium, are able to antagonize this pathway by delivering a bacterial effector protein that specifically cleaves Rab32 resulting in its degradation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.